Coccidioidomycosis during pregnancy: A review and recommendations for management

Robert S. Bercovitch, Antonino Catanzaro, Brian S. Schwartz, Demosthenes Pappagianis, Watts D.Heather Watts, Neil M. Ampel

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Abstract

Pregnancy is an established risk factor for the development of severe and disseminated coccidioidomycosis, particularly when infection is acquired during the later stages of gestation. Although recent studies suggest that the incidence of symptomatic coccidioidomycosis during pregnancy is decreasing and that outcome has improved, management is complicated by the observations that azole antifungal agents can be teratogenic when given to some women, particularly at high doses, early in pregnancy. This article summarizes the data on these issues and offers guidance on the management of coccidioidomycosis during pregnancy.

Original languageEnglish (US)
Pages (from-to)363-368
Number of pages6
JournalClinical Infectious Diseases
Volume53
Issue number4
DOIs
StatePublished - Aug 15 2011

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Coccidioidomycosis during pregnancy: A review and recommendations for management'. Together they form a unique fingerprint.

Cite this